Skip to main content
Premium Trial:

Request an Annual Quote

Trovagene Q3 Revenues Decline

NEW YORK (GenomeWeb News) – Trovagene reported after the close of the market Thursday that its third quarter revenues fell to $44,000 from $211,000 year over year.

All of the firm's revenues were derived from royalties, a company official said on a conference call following the release of the results.

Trovagene posted a net loss of $4.4 million, or $.25 per share, for the three month period ended Sept. 30, compared to a net loss of $660,000, or $.05 per share, for Q3 2012.

The company's R&D costs increased to $916,000 from $511,000, while its SG&A expenses tripled to $2.2 million from $739,000.

The San Diego-based molecular diagnostics firm recently launched its first oncogene mutation detection test, a cell-free BRAF detection test. Earlier in the year, it had launched its urine-based assay for human papillomavirus detection.

Trovagene CFO Stephen Zaniboni said on the call that during the remaining part of 2013 Trovagene will continue to develop and assay for detection of oncogene mutations in parallel, including an assay for detection of KRAS mutations that it hopes to launch by the end of this year.

Trovagene finished the quarter with $27.8 million in cash and cash equivalents.

Part of that cash came from a $15 million registered direct offering that the firm completed in July.

In Friday morning trade on the Nasdaq, shares of Trovagene were down a little more than 1 percent at $5.42.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.